Literature DB >> 6214994

Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests.

F H Kayser, G Morenzoni, F Homberger.   

Abstract

Examination of the activity of cefoperazone against ampicillin-resistant, gramnegative bacteria in agar dilution and simultaneously in broth dilution revealed that strains could be divided into three classes: class I strains were susceptible in agar (mean minimal inhibitory concentration [MIC], 0.5 mg/liter) as well as in broth dilution (mean MIC, 1.5 mg/liter), class II strains were susceptible in agar (MIC, 0.9 mg/liter), but resistant in broth dilution (MIC, 182 mg/liter); and class III strains were highly resistant in both test systems. Among 100 randomly selected ampicillin-resistant Escherichia coli cultures, 51 belonged to class I and 49 belonged to class II. Class III E. coli strains were much rarer. Similar results were obtained with cefamandole and cephalothin, but not with six other second-and third-generation cephalosporins. MICs of cefoperazone against cultures of all three classes were influenced by initial inoculum size. The inoculum effect was greatest with class II strains. Examination of bactericidal activity by cefoperazone showed killing of class I and class II E. coli strains and of class III strains of other genera during the first hours of incubation and regrowth after the drug was destroyed by the action of TEM beta-lactamase (penicillinase). Representative class I bacteria produced 10 to 100 times less TEM beta-lactamase than did class II strains. It appeared that the quantitative difference in TEM production was the reason for the different resistance phenotypes in class I and class II strains. Salmonella and Klebsiella strains of class III produced the same amounts of TEM beta-lactamase as did class II E. coli strains. Probably, some factors other than beta-lactamase contributed to the class III phenotype in these species.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214994      PMCID: PMC183666          DOI: 10.1128/AAC.22.1.15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  INHIBITION OF PENICILLINASES FROM GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA BY SUBSTRATE ANALOGUES.

Authors:  J M HAMILTON-MILLER; J T SMITH
Journal:  Nature       Date:  1964-03-07       Impact factor: 49.962

2.  NATURAL AND ACQUIRED RESISTANCE OF KLEBSIELLA-AEROBACTER TO CEPHALOTHIN AND CEPHALORIDINE.

Authors:  E J BENNER; J S MICKLEWAIT; J L BRODIE; W M KIRBY
Journal:  Proc Soc Exp Biol Med       Date:  1965-06

3.  Resistance categories of enterobacteria to beta-lactam antibiotics.

Authors:  D Greenwood; F O'Grady
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

6.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

7.  [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].

Authors:  B Schmid; F H Kayser
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-04

8.  Properties of an R factor from Pseudomonas aeruginosa.

Authors:  N Datta; R W Hedges; E J Shaw; R B Sykes; M H Richmond
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

9.  In vitro evaluation of cefoxitin and cefamandole.

Authors:  H G Adams; G A Stilwell; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

10.  Circular R-factor molecules controlling penicillinase synthesis, replicating in Escherichia coli under either relaxed or stringent control.

Authors:  P Kontomichalou; M Mitani; R C Clowes
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

View more
  11 in total

1.  The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

Authors:  F H Kayser; G Morenzoni; P Santanam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

2.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon.

Authors:  Joseph Gangoué-Piéboji; Branka Bedenic; Sinata Koulla-Shiro; Corinne Randegger; Dieudonné Adiogo; Pierre Ngassam; Peter Ndumbe; Herbert Hächler
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases.

Authors:  M T Nüesch-Inderbinen; H Hächler; F H Kayser
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

5.  The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.

Authors:  G Tischhauser; F H Kayser
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

6.  Quinolone resistance mechanisms in Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4,5,12:i:-, isolated from humans in Switzerland, and identification of a novel qnrD variant, qnrD2, in S. Hadar.

Authors:  Helga Abgottspon; Katrin Zurfluh; Magdalena Nüesch-Inderbinen; Herbert Hächler; Roger Stephan
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

Review 7.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

8.  Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland.

Authors:  Katrin Zurfluh; Helga Abgottspon; Herbert Hächler; Magdalena Nüesch-Inderbinen; Roger Stephan
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

9.  Vertical transmission of highly similar bla CTX-M-1-harboring IncI1 plasmids in Escherichia coli with different MLST types in the poultry production pyramid.

Authors:  Katrin Zurfluh; Juan Wang; Jochen Klumpp; Magdalena Nüesch-Inderbinen; Séamus Fanning; Roger Stephan
Journal:  Front Microbiol       Date:  2014-09-30       Impact factor: 5.640

10.  Replicon typing of plasmids carrying bla CTX-M-1 in Enterobacteriaceae of animal, environmental and human origin.

Authors:  Katrin Zurfluh; Gianna Jakobi; Roger Stephan; Herbert Hächler; Magdalena Nüesch-Inderbinen
Journal:  Front Microbiol       Date:  2014-10-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.